Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $416.91 | 16 | 96.5% |
| Education | $15.00 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $179.01 | 11 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $124.99 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $78.15 | 1 | $0 (2017) |
| Sandoz Inc. | $15.00 | 1 | $0 (2017) |
| LEO Pharma Inc. | $12.17 | 1 | $0 (2017) |
| Allergan Inc. | $11.50 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $11.09 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179.01 | 11 | ABBVIE INC. ($179.01) |
| 2019 | $11.09 | 1 | Janssen Biotech, Inc. ($11.09) |
| 2018 | $124.99 | 1 | Janssen Scientific Affairs, LLC ($124.99) |
| 2017 | $116.82 | 4 | Regeneron Healthcare Solutions, Inc. ($78.15) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.96 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: IMMUNOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Immunology | ||||||
| 04/19/2018 | Janssen Scientific Affairs, LLC | Tremfya (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 08/03/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: DERMATOLOGY | ||||||
| 06/23/2017 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $78.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/21/2017 | Sandoz Inc. | KERYDIN (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: DERMATOLOGY | ||||||
| 03/31/2017 | Allergan Inc. | ACZONE (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,037 | 1,299 | $119,310 | $63,952 |
| 2022 | 12 | 2,518 | 3,555 | $334,827 | $180,836 |
| 2021 | 14 | 3,015 | 4,310 | $400,213 | $234,238 |
| 2020 | 13 | 3,361 | 4,930 | $461,705 | $229,698 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 353 | 356 | $33,820 | $23,696 | 70.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 128 | $19,840 | $12,219 | 61.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 146 | 147 | $19,698 | $12,094 | 61.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 190 | 193 | $19,686 | $7,195 | 36.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 94 | 98 | $13,230 | $6,479 | 49.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 121 | 365 | $11,680 | $1,742 | 14.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 12 | 12 | $1,356 | $526.53 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 743 | 856 | $81,320 | $57,923 | 71.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 351 | 425 | $65,875 | $40,155 | 61.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 341 | 383 | $51,322 | $31,577 | 61.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 409 | 484 | $49,368 | $18,265 | 37.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 256 | 279 | $37,665 | $18,087 | 48.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 36 | 51 | $8,925 | $5,048 | 56.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 260 | 952 | $30,464 | $4,814 | 15.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $2,546 | $1,448 | 56.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 26 | 26 | $2,938 | $1,219 | 41.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 32 | 34 | $2,380 | $1,196 | 50.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 23 | $1,610 | $1,007 | 62.5% |
| 87220 | Tissue fungi or parasites | Office | 2022 | 22 | 23 | $414.00 | $96.64 | 23.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 836 | 1,011 | $92,945 | $71,017 | 76.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 430 | 551 | $73,820 | $54,339 | 73.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 409 | 478 | $64,052 | $40,038 | 62.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 316 | 366 | $48,220 | $24,895 | 51.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 456 | 572 | $58,344 | $22,230 | 38.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 300 | 1,042 | $33,344 | $5,130 | 15.4% |
About Dr. Fredric Brown, M.D
Dr. Fredric Brown, M.D is a Dermatology healthcare provider based in Kingston, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659317220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fredric Brown, M.D has received a total of $431.91 in payments from pharmaceutical and medical device companies, with $179.01 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($416.91).
As a Medicare-enrolled provider, Brown has provided services to 9,931 Medicare beneficiaries, totaling 14,094 services with total Medicare billing of $708,724. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Kingston, PA
- Active Since 06/21/2006
- Last Updated 02/26/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1659317220
Products in Payments
- Tremfya (Drug) $136.08
- RINVOQ (Biological) $124.99
- DUPIXENT DUPILUMAB INJECTION (Biological) $78.15
- SKYRIZI (Biological) $54.02
- KERYDIN (Drug) $15.00
- ENSTILAR (Drug) $12.17
- ACZONE (Drug) $11.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.